Lupin Pharmaceuticals Inc.: Liraglutide Injection, 18 Mg/3 Ml (6 Mg/ml)
Liraglutide Injection Recall Summary Lupin Pharmaceuticals is recalling Liraglutide Injection 18 mg/3 mL pens (used to treat diabetes and weight management) distributed nationwide because some cartridges contain a white thread-like particle inside. The affected products are 2-pen and 3-pen packages with specific NDC numbers. This is classified as a Class II recall, meaning the product could cause temporary health problems or serious adverse effects if used.
- Recalling firm
- Lupin Pharmaceuticals Inc.
- Product
- Liraglutide Injection, 18 mg/3 mL (6 mg/mL), Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Naples, FL 34108, Manufactured by: Lupin Limited, Nagpur 441108, INDIA, a) 2 Pens- NDC 70748-346-02; b) 3 Pens - NDC 70748-346-03.
- Reason
- Presence of particulate matter: a white thread-like structure in the cartridge
- Classification
- Class II
- Category
- drug recall
- Country
- United States
- Agency
- U.S. Food and Drug Administration
- Recall date
- 2026-04-24
- Status
- Ongoing
- Areas affected
- AL, AK, AZ, AR, CA, CO, CT, DE, FL, GA, HI, ID, ...
- Distribution
- Nationwide within U.S
Official recall notice from U.S. Food and Drug Administration
Recall details on Nibble Recalls: https://trynibble.app/recalls/d8701845-38f3-4a76-8f02-67ce4b1f014a